Physician profile
Basil Kaaki
NPI 1396162814
$18,578.32
in general payments reported to CMS, 2019-2025
6 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,282 · 2022: $9,728 · 2023: $2,799 · 2024: $2,534 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,260 · Travel and Lodging: $684 · Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,260.00 |
| Travel and Lodging | $683.88 |
| Food and Beverage | $624.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $13,062.68 | 2021-2024 | Xiaflex |
| Acerus Pharmaceuticals Corporation | $4,992.08 | 2022 | |
| Boston Scientific Corporation | $216.02 | 2023-2025 | Ams 700 |
| Tolmar, INC. | $184.08 | 2025 | Jatenzo |
| Antares Pharma, INC. | $100.00 | 2022-2023 | Tlando, Xyosted |
| Sumitomo Pharma America, INC. | $23.46 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basil Kaaki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.